46.22
price down icon2.61%   -1.24
after-market アフターアワーズ: 46.00 -0.22 -0.48%
loading
前日終値:
$47.46
開ける:
$47.32
24時間の取引高:
710.76K
Relative Volume:
0.61
時価総額:
$3.70B
収益:
-
当期純損益:
$-269.44M
株価収益率:
-12.33
EPS:
-3.75
ネットキャッシュフロー:
$-262.63M
1週間 パフォーマンス:
+0.04%
1か月 パフォーマンス:
-1.72%
6か月 パフォーマンス:
+2.17%
1年 パフォーマンス:
+65.07%
1日の値動き範囲:
Value
$46.16
$47.32
1週間の範囲:
Value
$44.53
$48.44
52週間の値動き範囲:
Value
$21.34
$58.40

Akero Therapeutics Inc Stock (AKRO) Company Profile

Name
名前
Akero Therapeutics Inc
Name
セクター
Healthcare (1143)
Name
電話
650-487-6488
Name
住所
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
Name
職員
67
Name
Twitter
@akerotx
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
AKRO's Discussions on Twitter

AKRO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AKRO
Akero Therapeutics Inc
46.22 3.80B 0 -269.44M -262.63M -3.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-04 再開されました H.C. Wainwright Buy
2025-08-04 開始されました TD Cowen Buy
2025-01-30 アップグレード BofA Securities Neutral → Buy
2025-01-27 繰り返されました H.C. Wainwright Buy
2024-11-18 開始されました Citigroup Buy
2024-04-22 再開されました BofA Securities Neutral
2023-09-19 開始されました Cantor Fitzgerald Overweight
2023-08-28 開始されました UBS Buy
2023-01-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-14 アップグレード Evercore ISI In-line → Outperform
2021-10-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-10 開始されました BofA Securities Buy
2021-02-26 開始されました Guggenheim Buy
2020-09-10 開始されました Morgan Stanley Overweight
2020-07-20 繰り返されました H.C. Wainwright Buy
2020-07-07 開始されました Chardan Capital Markets Buy
2020-07-01 繰り返されました H.C. Wainwright Buy
2020-03-02 開始されました H.C. Wainwright Buy
2020-02-10 開始されました Canaccord Genuity Buy
2019-07-15 開始されました Evercore ISI Outperform
2019-07-15 開始されました JP Morgan Overweight
2019-07-15 開始されました Jefferies Buy
2019-07-15 開始されました ROTH Capital Buy
すべてを表示

Akero Therapeutics Inc (AKRO) 最新ニュース

pulisher
Sep 24, 2025

Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience - The Globe and Mail

Sep 24, 2025
pulisher
Sep 23, 2025

Akero Therapeutics, Inc. $AKRO Shares Acquired by Voya Investment Management LLC - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Strs Ohio Acquires New Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Akero Therapeutics (NASDAQ:AKRO) Shares Gap UpTime to Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Akero Therapeutics, Inc. $AKRO Shares Bought by Intech Investment Management LLC - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Earnings Risk: Will Akero Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Target Return Focused Stock Picks - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Risk Analysis: Does Esperion Therapeutics Inc align with a passive investing strategyMarket Activity Recap & Fast Entry High Yield Stock Tips - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity - The Globe and Mail

Sep 20, 2025
pulisher
Sep 20, 2025

Fundamentals Check: Does Akero Therapeutics Inc meet Warren Buffetts criteriaTrade Signal Summary & AI Enhanced Trading Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

FOMO Trade: How does Akero Therapeutics Inc. score in quality rankingsStock Surge & Stock Market Timing Techniques - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

CCORF Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $73 - 富途牛牛

Sep 19, 2025
pulisher
Sep 19, 2025

NTLA Completes Enrollment in Pivotal Study on HAE Candidate, Stock Up - sharewise.com

Sep 19, 2025
pulisher
Sep 19, 2025

Hedge Fund Bets: Does Akero Therapeutics Inc. have consistent dividend growthWeekly Trade Review & Long-Term Growth Stock Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Morgan Stanley Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $84 - 富途牛牛

Sep 19, 2025
pulisher
Sep 18, 2025

Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023 - FinancialContent

Sep 18, 2025
pulisher
Sep 18, 2025

AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER - GlobeNewswire

Sep 18, 2025
pulisher
Sep 18, 2025

Pharma News: Why is Akero Therapeutics Inc stock going downJuly 2025 Patterns & Reliable Price Action Trade Plans - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

EV Market: What is the next catalyst for Northern Dynasty Minerals LtdTrade Exit Report & Weekly Breakout Stock Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Momentum Shift: Is PEBPRH stock a falling knife or bargain buyJuly 2025 Market Mood & Community Consensus Trade Signals - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Akero Therapeutics (NASDAQ:AKRO) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

LifeSci Capital Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Update: Can Apollomics Inc. Equity Warrant deliver consistent EPS growthJuly 2025 Setups & Safe Entry Trade Signal Reports - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Gains Report: Is Akero Therapeutics Inc backed by strong institutional buyingJuly 2025 Institutional & Technical Buy Zone Confirmations - khodrobank.com

Sep 18, 2025
pulisher
Sep 17, 2025

Aug EndMonth: Can CHARR ride the EV waveForecast Cut & Free Reliable Trade Execution Plans - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Analyst Calls: What is the implied volatility of Roundhill Etf Trust Roundhill Aapl Weeklypay EtfSell Signal & Free Growth Oriented Trading Recommendations - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Woodline Partners LP Acquires 100,769 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Block Trades: Should you avoid Akero Therapeutics Inc stock right nowWeekly Volume Report & AI Driven Stock Reports - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Spikes: Is Akero Therapeutics Inc stock good for income investorsMarket Sentiment Summary & Growth Focused Investment Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Winners Losers: What is Akero Therapeutics Incs revenue forecastWeekly Profit Recap & Daily Profit Maximizing Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Opening: Is Akero Therapeutics Inc stock influenced by commodity prices2025 Retail Activity & Low Risk High Win Rate Stock Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update - The Globe and Mail

Sep 16, 2025
pulisher
Sep 16, 2025

Analyst Calls: Is Akero Therapeutics Inc part of any major indexPortfolio Return Summary & Weekly High Conviction Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Risk Check: Can NDAQ sustain earnings growthTrade Signal Summary & Comprehensive Market Scan Insights - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Can Akero Therapeutics Inc deliver alphaMarket Activity Summary & Free Long-Term Investment Growth Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Portfolio Shifts: What is Baker Hughes Company’s TAM (Total Addressable Market)July 2025 Market Mood & Real-Time Market Trend Scan - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Death Cross: Can Akero Therapeutics Inc stock outperform in a bear marketJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Update Recap: Why is Akero Therapeutics Inc stock going downGap Up & Weekly Top Performers Watchlists - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Akero Therapeutics (NASDAQ:AKRO) Insider Timothy Rolph Sells 12,500 Shares - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Downgrade Watch: Is ProShares Trust ProShares Ultra Communication Services stock a buy or sellWeekly Gains Report & Expert-Curated Trade Recommendations - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Day Trade: Will Akero Therapeutics Inc benefit from government policyJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? - sharewise.com

Sep 15, 2025
pulisher
Sep 15, 2025

Momentum Shift: What hedge funds are buying Akero Therapeutics IncJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Patterns: Does Akero Therapeutics Inc offer margin of safety2025 Stock Rankings & Consistent Growth Equity Picks - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Buyout Rumor: Is Akero Therapeutics Inc part of any major index2025 Trade Ideas & Long-Term Growth Stock Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Market Fear: Is Akero Therapeutics Inc. stock a falling knife or bargain buyJuly 2025 Summary & Reliable Intraday Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

US Market Wrap: Will M tron Industries Inc benefit from sector rotation2025 Breakouts & Breakdowns & AI Forecast Swing Trade Picks - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Market Wrap: What is the earnings history of Akero Therapeutics IncQuarterly Trade Summary & AI Optimized Trading Strategy Guides - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

Akero Therapeutics Inc. stock prediction for this weekCEO Change & Entry Point Confirmation Signals - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Fred Alger Management LLC Grows Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Exome Asset Management LLC Boosts Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Akero Therapeutics COO sells $25k in shares By Investing.com - Investing.com South Africa

Sep 13, 2025

Akero Therapeutics Inc (AKRO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):